A comparison of the effects of hexobendine with those of anoxia on the concentration of myocardial metabolites in vivo.
D000255:Adenosine Triphosphate / Q000032:analysis; D000818:Animals; D002951:Citrates / Q000032:analysis; D005029:Ethylenediamines / Q000494:pharmacology*; D005215:Fasting; D005227:Fatty Acids / Q000032:analysis; D005994:Glycerophosphates / Q000032:analysis; D006003:Glycogen / Q000032:analysis; D006600:Hexosephosphates / Q000032:analysis; D000860:Hypoxia / Q000378:metabolism*; D007275:Injections, Intravenous; D007773:Lactates / Q000032:analysis; D008293:Malates / Q000032:analysis; D008297:Male; D009206:Myocardium / Q000378:metabolism*; D011773:Pyruvates / Q000032:analysis; D051381:Rats; D014306:Trioses / Q000032:analysis
D002951:Citrates; D005029:Ethylenediamines; D005227:Fatty Acids; D005994:Glycerophosphates; D006600:Hexosephosphates; D007773:Lactates; D008293:Malates; D011773:Pyruvates; D014306:Trioses; D000255:Adenosine Triphosphate; D006003:Glycogen